首页 > 最新文献

European Journal of Translational and Clinical Medicine最新文献

英文 中文
Effect of Sinovac or Biontech Vaccination on Mortality in COVID-19 Patients in The Intensive Care Unit 新科与生物技术疫苗接种对重症监护病房COVID-19患者死亡率的影响
Q4 Medicine Pub Date : 2022-06-18 DOI: 10.24018/clinicmed.2022.3.3.210
Ülkü İnce, Harun Duran, Y. Yıldırım
Introduction: COVID-19 infection has spread with the development of the pandemic and is transmitted by respiratory droplets. The level of protection of vaccines administered together with the COVID-19 vaccine is the subject of research. We aimed to examine intensive care patients with Sinovac and Biontech vaccines. Material and Method: After the approval of the ethics committee, 45 patient data were included in our study. Vaccination status in intensive care units was examined and patients were grouped into Sinovac and Biontech. Age, sex, comorbid conditions, and mortality rates were compared statistically. With this comparison, the effects on mortality and clinical features were evaluated. Results: Forty-five patients between March 31 and December 31, 2021 were included in the study. In these patients, patients who received 2 doses of vaccine in the period before hospitalization according to the intensive care evaluation criteria were examined. Mortality rates were higher in patients who received 2 doses of Sinovac vaccine in patients hospitalized in the intensive care unit compared to those who received 2 doses of Biontech vaccine. Conclusion: It was observed that the vaccination status of patients who were vaccinated with COVID-19 and taken to the intensive care unit affected mortality. Studies with larger numbers of patients are needed.
导语:COVID-19感染随着大流行的发展而传播,并通过呼吸道飞沫传播。与COVID-19疫苗一起接种的疫苗的保护水平是研究的主题。我们的目的是检查重症监护患者使用科兴和Biontech疫苗。材料和方法:经伦理委员会批准,45例患者资料纳入我们的研究。对重症监护病房的疫苗接种情况进行了检查,并将患者分为科兴和Biontech两组。年龄、性别、合并症和死亡率进行统计学比较。通过比较,评估对死亡率和临床特征的影响。结果:45例患者于2021年3月31日至12月31日纳入研究。在这些患者中,根据重症监护评估标准对住院前接受2剂疫苗接种的患者进行检查。在重症监护病房住院的患者中,接受两剂科兴疫苗的患者死亡率高于接受两剂Biontech疫苗的患者。结论:观察到接种COVID-19疫苗并进入重症监护病房的患者的疫苗接种状况影响死亡率。需要对大量患者进行研究。
{"title":"Effect of Sinovac or Biontech Vaccination on Mortality in COVID-19 Patients in The Intensive Care Unit","authors":"Ülkü İnce, Harun Duran, Y. Yıldırım","doi":"10.24018/clinicmed.2022.3.3.210","DOIUrl":"https://doi.org/10.24018/clinicmed.2022.3.3.210","url":null,"abstract":"Introduction: COVID-19 infection has spread with the development of the pandemic and is transmitted by respiratory droplets. The level of protection of vaccines administered together with the COVID-19 vaccine is the subject of research. We aimed to examine intensive care patients with Sinovac and Biontech vaccines. \u0000Material and Method: After the approval of the ethics committee, 45 patient data were included in our study. Vaccination status in intensive care units was examined and patients were grouped into Sinovac and Biontech. Age, sex, comorbid conditions, and mortality rates were compared statistically. With this comparison, the effects on mortality and clinical features were evaluated. \u0000Results: Forty-five patients between March 31 and December 31, 2021 were included in the study. In these patients, patients who received 2 doses of vaccine in the period before hospitalization according to the intensive care evaluation criteria were examined. Mortality rates were higher in patients who received 2 doses of Sinovac vaccine in patients hospitalized in the intensive care unit compared to those who received 2 doses of Biontech vaccine. \u0000Conclusion: It was observed that the vaccination status of patients who were vaccinated with COVID-19 and taken to the intensive care unit affected mortality. Studies with larger numbers of patients are needed.","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72527358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HRCT Evaluation of Post Vaccinated RT-PCR Positive COVID-19 Patients at A Dedicated COVID-19 Hospital 某新型冠状病毒感染专科医院新冠病毒接种后RT-PCR阳性患者的HRCT评价
Q4 Medicine Pub Date : 2022-06-18 DOI: 10.24018/clinicmed.2022.3.3.192
Md Tanzilur Rahman, Md. Iftadul Islam, Nishat Un Nahar, M. Ibrahim, H. Zubery, M. Shirin
Background: Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Large-scale vaccination of risk groups and later the general population is the single most effective public health measure for mitigation of the COVID-19 pandemic. Methods and Materials: This prospective cross sectional study was carried out at Dhaka North City Corporation dedicated COVID-19 hospital, Mohakhali, Dhaka, enrolling 50 (fifty) vaccinated RT-PCR positive COVID-19 patients. Results: Majority of the patients were >50 years old. Most of the patients had bilateral lung involvement and ground glass was the predominant CT pattern. 20% patients had consolidation in HRCT scan. Most of the patients (46%) had mild disease and only 18% patients had severe disease. Severe cases were more common (77.8%) in older (>50years) patients. 20% of the patients had 50-75% and only 6 % patients had more than 75% of total lung involvement. 52% patients had less than 25% lung involvement. Lung involvement was significantly higher in older patients. Patients had to stay an average of 6.2 days in hospital. Older patients had to stay more days in the hospital than younger patients. 2% (1) of COVID-19 patients died after admitting into our hospital. Conclusion: Vaccination can effectively reduce mortality and morbidity of COVID-19 patients by reducing the active number of cases as well as severity of the disease.
背景:冠状病毒病2019 (COVID-19)是由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的一种高度传染性疾病。对危险人群以及随后的普通人群进行大规模疫苗接种是缓解COVID-19大流行的唯一最有效的公共卫生措施。方法和材料:本前瞻性横断面研究在达卡Mohakhali的Dhaka North City Corporation专用COVID-19医院进行,纳入50(50)例接种RT-PCR阳性COVID-19疫苗的患者。结果:大多数患者年龄>50岁。大多数患者举行了双边肺参与和磨砂玻璃的主要CT模式。20%的患者合并HRCT扫描。大多数患者(46%)有轻度疾病,只有18%的患者有严重疾病。严重的情况下更为常见(77.8%)在老年(> 50年)患者。20%的患者有50-75%,只有6%的患者有超过75%的肺部受累。52%的患者肺部受累程度小于25%。老年患者肺部受累明显更高。患者平均住院时间为6.2天。老年患者不得不呆几天在医院比年轻病人。2%(1)的新冠肺炎患者入院后死亡。结论:疫苗接种可通过降低活跃病例数和病情严重程度,有效降低COVID-19患者的死亡率和发病率。
{"title":"HRCT Evaluation of Post Vaccinated RT-PCR Positive COVID-19 Patients at A Dedicated COVID-19 Hospital","authors":"Md Tanzilur Rahman, Md. Iftadul Islam, Nishat Un Nahar, M. Ibrahim, H. Zubery, M. Shirin","doi":"10.24018/clinicmed.2022.3.3.192","DOIUrl":"https://doi.org/10.24018/clinicmed.2022.3.3.192","url":null,"abstract":"Background: Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Large-scale vaccination of risk groups and later the general population is the single most effective public health measure for mitigation of the COVID-19 pandemic. \u0000Methods and Materials: This prospective cross sectional study was carried out at Dhaka North City Corporation dedicated COVID-19 hospital, Mohakhali, Dhaka, enrolling 50 (fifty) vaccinated RT-PCR positive COVID-19 patients. \u0000Results: Majority of the patients were >50 years old. Most of the patients had bilateral lung involvement and ground glass was the predominant CT pattern. 20% patients had consolidation in HRCT scan. Most of the patients (46%) had mild disease and only 18% patients had severe disease. Severe cases were more common (77.8%) in older (>50years) patients. 20% of the patients had 50-75% and only 6 % patients had more than 75% of total lung involvement. 52% patients had less than 25% lung involvement. Lung involvement was significantly higher in older patients. Patients had to stay an average of 6.2 days in hospital. Older patients had to stay more days in the hospital than younger patients. 2% (1) of COVID-19 patients died after admitting into our hospital. \u0000Conclusion: Vaccination can effectively reduce mortality and morbidity of COVID-19 patients by reducing the active number of cases as well as severity of the disease.","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82864129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Classic Sweet Syndrome with Mucosal Involvement 经典甜综合征伴粘膜受累
Q4 Medicine Pub Date : 2022-06-13 DOI: 10.24018/clinicmed.2022.3.3.211
Madiha Ahmed, A. Khan, Rameez Rao, A. Bui, S. Carlan
Sweet syndrome is an uncommon disorder of unknown etiology and characterized by skin and systemic inflammation. Classic Sweet syndrome is not associated with malignancy or drug exposure and typically involves elderly females. A 67-year-old female with a past medical history of multiple sclerosis and chronic kidney disease presented with worsening erythema of bilateral lower extremities, and diffuse, tender pustular lesions in her extremities, eye lids, nares, oral commissures, and tongue. A biopsy revealed marked neutrophilic inflammation suggestive of Sweet syndrome and she was started on high dose methylprednisolone which immediately improved her condition. As with most progressive inflammatory diseases, early recognition and early treatment improves the prognosis. This case is unusual because of mucosal involvement at presentation. Classic Sweet syndrome can often be diagnosed by exclusion after failed treatment for either infectious or autoimmune disorders.
甜综合征是一种病因不明的罕见疾病,以皮肤和全身炎症为特征。经典Sweet综合征与恶性肿瘤或药物暴露无关,通常涉及老年女性。67岁女性,既往有多发性硬化症和慢性肾脏疾病病史,表现为双侧下肢红斑加重,四肢、眼睑、鼻腔、口腔交界和舌头出现弥漫性、压痛性脓疱性病变。活检显示明显的中性粒细胞炎症,提示Sweet综合征,她开始使用大剂量甲基强的松龙,立即改善了她的病情。与大多数进行性炎性疾病一样,早期识别和早期治疗可改善预后。本病例不常见,因为表现时粘膜受累。经典的Sweet综合征通常可以在感染性或自身免疫性疾病治疗失败后通过排除来诊断。
{"title":"Classic Sweet Syndrome with Mucosal Involvement","authors":"Madiha Ahmed, A. Khan, Rameez Rao, A. Bui, S. Carlan","doi":"10.24018/clinicmed.2022.3.3.211","DOIUrl":"https://doi.org/10.24018/clinicmed.2022.3.3.211","url":null,"abstract":"Sweet syndrome is an uncommon disorder of unknown etiology and characterized by skin and systemic inflammation. Classic Sweet syndrome is not associated with malignancy or drug exposure and typically involves elderly females. A 67-year-old female with a past medical history of multiple sclerosis and chronic kidney disease presented with worsening erythema of bilateral lower extremities, and diffuse, tender pustular lesions in her extremities, eye lids, nares, oral commissures, and tongue. A biopsy revealed marked neutrophilic inflammation suggestive of Sweet syndrome and she was started on high dose methylprednisolone which immediately improved her condition. As with most progressive inflammatory diseases, early recognition and early treatment improves the prognosis. This case is unusual because of mucosal involvement at presentation. Classic Sweet syndrome can often be diagnosed by exclusion after failed treatment for either infectious or autoimmune disorders.","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81655354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disseminated Hematogenous Tuberculosis after Spontaneous Abortion 自然流产后播散性血结核
Q4 Medicine Pub Date : 2022-06-06 DOI: 10.24018/clinicmed.2022.3.3.209
Sarah R. Cheyney, Rena Ow, C. Verdick, Mary Reischmann, S. Carlan
Disseminated tuberculosis is a mycobacterial infection that either involves the blood, bone marrow, liver or two or more noncontiguous sites. While tuberculosis is not uncommon in pregnancy, active, disseminated tuberculosis is exceedingly rare and is associated with poor maternal and fetal outcomes including a ninefold increase in miscarriage. Symptoms of both disseminated tuberculosis in pregnancy can be vague and nonspecific making it difficult to diagnosis. A 20-year-old, immune competent female presented with worsening dyspnea over two months and cavitary lesions on chest imaging. She had been treated with oral antibiotics two months prior and was noted to have an early intrauterine pregnancy at the time. She subsequently miscarried spontaneously. PCR (polymerase chain reaction) testing from brochoalveolar lavage isolated Mycobacterium Tuberculosis. A liquid biopsy (Karius) was positive for Cytomegalovirus, Herpes Simplex Virus 1, and Candida Albicans. The patient had a prolonged and complicated treatment course and ultimately was discharged to inpatient rehabilitation. Disseminated tuberculosis is associated with significant mortality and morbidity warranting prompt treatment with clinical suspicion. Treatment should start when active TB is diagnosed in pregnancy regardless of the trimester. The prenatal care giver is in a unique position to screen and support women who otherwise may not interact with a structured healthcare system.
播散性结核是一种分枝杆菌感染,可累及血液、骨髓、肝脏或两个或多个不连续部位。虽然结核病在怀孕期间并不罕见,但活动性、播散性结核病极为罕见,并与孕产妇和胎儿预后不良有关,包括流产率增加9倍。妊娠期播散性肺结核的症状可能模糊且非特异性,因此难以诊断。一位20岁,免疫功能正常的女性,在两个多月的时间里呼吸困难加重,胸部影像学显示有空洞病变。她在两个月前接受了口服抗生素治疗,当时被发现有早期宫内妊娠。后来她自然流产了。支气管肺泡灌洗液分离结核分枝杆菌的PCR检测。液体活检(卡里乌斯)巨细胞病毒、单纯疱疹病毒1型和白色念珠菌阳性。患者的治疗过程漫长而复杂,最终出院住院康复。播散性结核病与显著的死亡率和发病率相关,需要在临床怀疑的情况下及时治疗。无论妊娠期的哪个阶段,只要诊断出活动性结核病,就应开始治疗。产前护理提供者在筛查和支持妇女方面处于独特的地位,否则她们可能无法与结构化的医疗保健系统互动。
{"title":"Disseminated Hematogenous Tuberculosis after Spontaneous Abortion","authors":"Sarah R. Cheyney, Rena Ow, C. Verdick, Mary Reischmann, S. Carlan","doi":"10.24018/clinicmed.2022.3.3.209","DOIUrl":"https://doi.org/10.24018/clinicmed.2022.3.3.209","url":null,"abstract":"Disseminated tuberculosis is a mycobacterial infection that either involves the blood, bone marrow, liver or two or more noncontiguous sites. While tuberculosis is not uncommon in pregnancy, active, disseminated tuberculosis is exceedingly rare and is associated with poor maternal and fetal outcomes including a ninefold increase in miscarriage. Symptoms of both disseminated tuberculosis in pregnancy can be vague and nonspecific making it difficult to diagnosis. A 20-year-old, immune competent female presented with worsening dyspnea over two months and cavitary lesions on chest imaging. She had been treated with oral antibiotics two months prior and was noted to have an early intrauterine pregnancy at the time. She subsequently miscarried spontaneously. PCR (polymerase chain reaction) testing from brochoalveolar lavage isolated Mycobacterium Tuberculosis. A liquid biopsy (Karius) was positive for Cytomegalovirus, Herpes Simplex Virus 1, and Candida Albicans. The patient had a prolonged and complicated treatment course and ultimately was discharged to inpatient rehabilitation. Disseminated tuberculosis is associated with significant mortality and morbidity warranting prompt treatment with clinical suspicion. Treatment should start when active TB is diagnosed in pregnancy regardless of the trimester. The prenatal care giver is in a unique position to screen and support women who otherwise may not interact with a structured healthcare system.","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86140306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Black Soybean (Glycine max (L.) Merr.) 30% Ethanol Extract Cream Inhibited The Increase of Tyrosinase Enzyme Expression and The Amount of Melanin Same Effective as 4% Hydroquinone Cream on Guinea Pig (Cavia porcellus) Skin 黑豆(Glycine max (L.))30%乙醇提取物乳膏对豚鼠(Cavia porcellus)皮肤酪氨酸酶表达和黑色素含量的抑制作用与4%对苯二酚乳膏相同
Q4 Medicine Pub Date : 2022-06-06 DOI: 10.24018/clinicmed.2022.3.3.212
Yanvi Johan, A. A. Wiraguna, N. N. A. Dewi
Background: Hyperpigmentation is one of the signs of skin aging which is mostly caused by Ultraviolet B (UVB) rays exposure. The gold standard for hyperpigmentation therapy is hydroquinone (HQ) but its long-term use can cause side effects such as irritation, rebound phenomenon, and even ochronosis. Black soybeans contain active ingredients that can prevent the increase of tyrosinase enzyme and the amount of melanin so that it can be used as an alternative therapy for hyperpigmentation. This study aims to prove that the administration of 30% black soybean extract cream was as effective as 4% HQ cream in inhibiting the increase of tyrosinase enzyme expression and the amount of melanin in guinea pig skin exposed to UVB rays. Methods: This study used a post-test only control group design method with 30 guinea pigs as samples. The sample was divided into three groups of 10 each. The P1 group was given the base cream, the P2 group was given the 4% HQ cream, while the P3 group was given the 30% black soybean extract cream. Each group was exposed to UVB rays with a total dose of 390mJ/cm2 for 2 weeks, after that the guinea pig skin tissue was taken and histopathological preparations were made for examination of tyrosinase enzyme expression and the amount of melanin. The data obtained were analyzed using one way ANOVA, then the differences between groups were analyzed using the Least Significant Difference (LSD) test. Results: The results showed that the mean of the tyrosinase enzyme expression and the amount of melanin in the black soybean extract group P3 (12.880±3.327% and 3.16±1.486) were not significantly different from the HQ4% group P2 (9.690±2.176% and 2.18±1.117), while the mean of the base cream group P1 (25.78±5.392% and 12.080±3.150) was the highest among the three groups. The LSD test showed a significant difference between the base cream group (P1) and the other groups (p<0.01), but there was no significant difference between the 4% hydroquinone group (P2) and the 30% black soybean extract treatment group (P3) (p >0.05). Conclusion: The conclusion of this study was that 30% black soybean ethanol extract cream inhibited the increase of tyrosinase enzyme expression and the amount of melanin as effective as 4% HQ cream on guinea pig skin exposed to UVB light.
背景:色素沉着是皮肤老化的标志之一,它主要是由紫外线B (UVB)射线照射引起的。治疗色素沉着症的金标准是对苯二酚(HQ),但长期使用会产生副作用,如刺激、反弹现象,甚至是衰老。黑大豆含有有效成分,可以防止酪氨酸酶和黑色素的增加,因此它可以作为色素沉着的替代疗法。本研究旨在证明30%黑大豆提取物乳膏与4% HQ乳膏在抑制UVB照射下豚鼠皮肤酪氨酸酶表达和黑色素量增加方面的效果相同。方法:本研究以30只豚鼠为样本,采用后验组设计方法。样本被分成三组,每组10人。P1组给予基础乳膏,P2组给予4% HQ乳膏,P3组给予30%黑豆豉膏。各组接受总剂量为390mJ/cm2的UVB照射2周后,取豚鼠皮肤组织,做组织病理学准备,检测酪氨酸酶表达及黑色素含量。所得数据采用单因素方差分析,组间差异采用Least Significant Difference (LSD)检验。结果:黑豆豉提取物P3组酪氨酸酶表达量均值(12.880±3.327%、3.16±1.486)与HQ4% P2组(9.690±2.176%、2.18±1.117)差异无统计学意义,底霜P1组(25.78±5.392%、12.080±3.150)均值最高。LSD检验显示,底霜组(P1)与其他组比较差异有统计学意义(p0.05)。结论:30%黑大豆乙醇提取物乳膏对UVB光下豚鼠皮肤酪氨酸酶表达和黑色素含量的抑制作用与4% HQ乳膏相当。
{"title":"Black Soybean (Glycine max (L.) Merr.) 30% Ethanol Extract Cream Inhibited The Increase of Tyrosinase Enzyme Expression and The Amount of Melanin Same Effective as 4% Hydroquinone Cream on Guinea Pig (Cavia porcellus) Skin","authors":"Yanvi Johan, A. A. Wiraguna, N. N. A. Dewi","doi":"10.24018/clinicmed.2022.3.3.212","DOIUrl":"https://doi.org/10.24018/clinicmed.2022.3.3.212","url":null,"abstract":"Background: Hyperpigmentation is one of the signs of skin aging which is mostly caused by Ultraviolet B (UVB) rays exposure. The gold standard for hyperpigmentation therapy is hydroquinone (HQ) but its long-term use can cause side effects such as irritation, rebound phenomenon, and even ochronosis. Black soybeans contain active ingredients that can prevent the increase of tyrosinase enzyme and the amount of melanin so that it can be used as an alternative therapy for hyperpigmentation. This study aims to prove that the administration of 30% black soybean extract cream was as effective as 4% HQ cream in inhibiting the increase of tyrosinase enzyme expression and the amount of melanin in guinea pig skin exposed to UVB rays. Methods: This study used a post-test only control group design method with 30 guinea pigs as samples. The sample was divided into three groups of 10 each. The P1 group was given the base cream, the P2 group was given the 4% HQ cream, while the P3 group was given the 30% black soybean extract cream. Each group was exposed to UVB rays with a total dose of 390mJ/cm2 for 2 weeks, after that the guinea pig skin tissue was taken and histopathological preparations were made for examination of tyrosinase enzyme expression and the amount of melanin. The data obtained were analyzed using one way ANOVA, then the differences between groups were analyzed using the Least Significant Difference (LSD) test. Results: The results showed that the mean of the tyrosinase enzyme expression and the amount of melanin in the black soybean extract group P3 (12.880±3.327% and 3.16±1.486) were not significantly different from the HQ4% group P2 (9.690±2.176% and 2.18±1.117), while the mean of the base cream group P1 (25.78±5.392% and 12.080±3.150) was the highest among the three groups. The LSD test showed a significant difference between the base cream group (P1) and the other groups (p<0.01), but there was no significant difference between the 4% hydroquinone group (P2) and the 30% black soybean extract treatment group (P3) (p >0.05). Conclusion: The conclusion of this study was that 30% black soybean ethanol extract cream inhibited the increase of tyrosinase enzyme expression and the amount of melanin as effective as 4% HQ cream on guinea pig skin exposed to UVB light.","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77838957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difference of Complete Blood Count (CBC) between Patient with Sudden Deafness and Control at Sanglah General Hospital from January 2018-March 2021 2018年1月- 2021年3月桑格拉总医院突发性耳聋患者与对照组全血细胞计数(CBC)的差异
Q4 Medicine Pub Date : 2022-06-06 DOI: 10.24018/clinicmed.2022.3.3.155
Sylvia Sylvia, Made Wiranadha
Introduction: Sudden deafness is sudden sensorineural hearing loss (SSNHL) of at least 30 db or more in three contiguous frequencies, occurring within 72 hours. 10-15% is caused by underlying disease, while the others are idiopathic. Prognosis are difficult to predict. Complete blood count (CBC) is a basic examination that can be done in almost all medical facility. Few researches have shown a significant difference in hematocrit, NLR,PLR, MLR, RDW and MPV between patients and control . Methods: This study was an analytic study with retrospective case control study design Results: There are differences in level of hematocrit, NLR, PLR among patients with sudden sensorineural hearing loss and control in Sanglah hospital Denpasar (p<0.05, CI 95%) Conclusion: There was a difference in hematocrit, NLR and PLR between patients with sudden deafness and control at Sanglah General Hospital, Denpasar.
简介:突发性耳聋是指在72小时内发生的三个连续频率至少为30db或以上的突发性感音神经性听力损失(SSNHL)。10-15%是由基础疾病引起的,而其他是特发性的。预后很难预测。全血细胞计数(CBC)是一项基本检查,几乎在所有医疗机构都可以完成。很少有研究显示患者与对照组的红细胞压积、NLR、PLR、MLR、RDW和MPV有显著差异。方法:本研究为回顾性病例对照研究设计的分析性研究。结果:登巴萨Sanglah总医院突发性感音神经性耳聋患者与对照组的红细胞压积、NLR、PLR水平存在差异(p<0.05, CI 95%)。结论:登巴萨Sanglah总医院突发性耳聋患者与对照组的红细胞压积、NLR、PLR水平存在差异。
{"title":"Difference of Complete Blood Count (CBC) between Patient with Sudden Deafness and Control at Sanglah General Hospital from January 2018-March 2021","authors":"Sylvia Sylvia, Made Wiranadha","doi":"10.24018/clinicmed.2022.3.3.155","DOIUrl":"https://doi.org/10.24018/clinicmed.2022.3.3.155","url":null,"abstract":"Introduction: Sudden deafness is sudden sensorineural hearing loss (SSNHL) of at least 30 db or more in three contiguous frequencies, occurring within 72 hours. 10-15% is caused by underlying disease, while the others are idiopathic. Prognosis are difficult to predict. Complete blood count (CBC) is a basic examination that can be done in almost all medical facility. Few researches have shown a significant difference in hematocrit, NLR,PLR, MLR, RDW and MPV between patients and control . \u0000Methods: This study was an analytic study with retrospective case control study design \u0000Results: There are differences in level of hematocrit, NLR, PLR among patients with sudden sensorineural hearing loss and control in Sanglah hospital Denpasar (p<0.05, CI 95%) \u0000Conclusion: There was a difference in hematocrit, NLR and PLR between patients with sudden deafness and control at Sanglah General Hospital, Denpasar.","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73532456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of antihistamines for COVID-19 vaccine recipients with risk of anaphylaxis 对有过敏反应风险的COVID-19疫苗接种者使用抗组胺药
Q4 Medicine Pub Date : 2022-05-31 DOI: 10.31373/ejtcm/138219
Jakub Grabowski, M. Wolff, Samuel Pettersson, Tomasz Brancewicz, L. Bidzan
Corresponding author: Samuel D Pettersson, Neurology and Neurosurgery Scientific Circle, Department of Neurosurgery, Medical University of Gdańsk, Poland e-mail: samueldpettersson@gumed.edu.pl Available online: www.ejtcm.gumed.edu.pl Copyright ® Medical University of Gdańsk This is Open Access article distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International. TRANSPARENT PROCESS OPEN ACCESS Abstract
通讯作者:Samuel D Pettersson,神经病学和神经外科科学圈,神经外科学系,波兰医科大学Gdańsk e-mail: samueldpettersson@gumed.edu.pl在线可用:www.ejtcm.gumed.edu.pl版权所有®Gdańsk医科大学这是一篇开放获取的文章,在知识共享署名-共享方式4.0国际协议的条款下分发。透明过程开放存取摘要
{"title":"Use of antihistamines for COVID-19 vaccine recipients with risk of anaphylaxis","authors":"Jakub Grabowski, M. Wolff, Samuel Pettersson, Tomasz Brancewicz, L. Bidzan","doi":"10.31373/ejtcm/138219","DOIUrl":"https://doi.org/10.31373/ejtcm/138219","url":null,"abstract":"Corresponding author: Samuel D Pettersson, Neurology and Neurosurgery Scientific Circle, Department of Neurosurgery, Medical University of Gdańsk, Poland e-mail: samueldpettersson@gumed.edu.pl Available online: www.ejtcm.gumed.edu.pl Copyright ® Medical University of Gdańsk This is Open Access article distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International. TRANSPARENT PROCESS OPEN ACCESS Abstract","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44386796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The importance of obesity and carbohydrate metabolism disorders on the course of gastroesophageal reflux disease – a pilot study 肥胖和碳水化合物代谢紊乱在胃食管反流病病程中的重要性——一项初步研究
Q4 Medicine Pub Date : 2022-05-31 DOI: 10.31373/ejtcm/149190
Piotr Pardak, R. Filip, Maciej Krzaczek
Corresponding author: Piotr Pardak, Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, Rzeszów, Poland (affiliated with the Medical College of Rzeszów University, Poland), Department of Internal Medicine, Institute of Rural Health, Lublin, Poland e-mail: piotrpardak@wp.pl Available online: www.ejtcm.gumed.edu.pl Copyright ® Medical University of Gdańsk This is Open Access article distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International. TRANSPARENT PROCESS OPEN ACCESS Abstract
通讯作者:Piotr Pardak,波兰Rzeszów第二临床医院IBD消化内科(隶属于波兰Rzeszów大学医学院),波兰卢布林农村卫生研究所内科,e-mail: piotrpardak@wp.pl在线提供:www.ejtcm.gumed.edu.pl版权所有®Gdańsk医科大学这是一篇开放获取的文章,根据知识共享署名-相似方式共享4.0国际的条款分发。透明过程开放存取摘要
{"title":"The importance of obesity and carbohydrate metabolism disorders on the course of gastroesophageal reflux disease – a pilot study","authors":"Piotr Pardak, R. Filip, Maciej Krzaczek","doi":"10.31373/ejtcm/149190","DOIUrl":"https://doi.org/10.31373/ejtcm/149190","url":null,"abstract":"Corresponding author: Piotr Pardak, Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, Rzeszów, Poland (affiliated with the Medical College of Rzeszów University, Poland), Department of Internal Medicine, Institute of Rural Health, Lublin, Poland e-mail: piotrpardak@wp.pl Available online: www.ejtcm.gumed.edu.pl Copyright ® Medical University of Gdańsk This is Open Access article distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International. TRANSPARENT PROCESS OPEN ACCESS Abstract","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46247510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mutual relations between the amygdala and pro-inflammatory cytokines: IL-1β and IL-6 杏仁核与促炎细胞因子IL-1β和IL-6的相互关系
Q4 Medicine Pub Date : 2022-05-31 DOI: 10.31373/ejtcm/134675
K. Czerwiec, Jan Ruciński, G. Piwko, D. Myślińska, A. Kosiński
Interleukin 1 (IL-1) and interleukin 6 (IL-6) are typical examples of multifunctional pro-inflammatory cytokines involved in the regulation of the immune response, hematopoiesis, and inflammation. Both peripheral and in traventricular administration of these cytokines causes acute phase symptoms, e.g. fever, activation of the hypo -thalamic-pituitary-adrenal axis and psychological depression. The amygdala belongs to the structures of the lim bic system involved in the regulation of the immune response. Increased activity of immune system may lead to changes in the role of amygdala, medial prefrontal cortex, anterior cingulate cortex or insula. The aim of the study was to present the mutual interactions between the amygdala and pro-inflammatory cytokines such as interleu kin 1-beta (IL-1 beta) and interleukin 6 (IL-6). Most of the data included in this review comes from animal studies.
白介素1(IL-1)和白介素6(IL-6)是参与调节免疫反应、造血和炎症的多功能促炎细胞因子的典型例子。这些细胞因子的外周和脑室内给药都会引起急性期症状,如发烧、下丘脑-垂体-肾上腺轴激活和心理抑郁。杏仁核属于参与免疫反应调节的lim-bic系统的结构。免疫系统活动的增加可能导致杏仁核、内侧前额叶皮层、前扣带皮层或脑岛的作用发生变化。本研究的目的是介绍杏仁核与促炎细胞因子如白细胞介素1β(IL-1β)和白细胞介因子6(IL-6)之间的相互作用。这篇综述中包含的大部分数据来自动物研究。
{"title":"Mutual relations between the amygdala and pro-inflammatory cytokines: IL-1β and IL-6","authors":"K. Czerwiec, Jan Ruciński, G. Piwko, D. Myślińska, A. Kosiński","doi":"10.31373/ejtcm/134675","DOIUrl":"https://doi.org/10.31373/ejtcm/134675","url":null,"abstract":"Interleukin 1 (IL-1) and interleukin 6 (IL-6) are typical examples of multifunctional pro-inflammatory cytokines involved in the regulation of the immune response, hematopoiesis, and inflammation. Both peripheral and in traventricular administration of these cytokines causes acute phase symptoms, e.g. fever, activation of the hypo -thalamic-pituitary-adrenal axis and psychological depression. The amygdala belongs to the structures of the lim bic system involved in the regulation of the immune response. Increased activity of immune system may lead to changes in the role of amygdala, medial prefrontal cortex, anterior cingulate cortex or insula. The aim of the study was to present the mutual interactions between the amygdala and pro-inflammatory cytokines such as interleu kin 1-beta (IL-1 beta) and interleukin 6 (IL-6). Most of the data included in this review comes from animal studies.","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43060833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Duodenal diverticulum perforation mimicking acute cholecystitis- case reports and literature review 十二指肠憩室穿孔模拟急性胆囊炎1例报告及文献复习
Q4 Medicine Pub Date : 2022-05-31 DOI: 10.31373/ejtcm/139692
Monika Łącka, S. Hać
Corresponding author: Monika Łącka, Department of General, Endoctrine and Transplant Surgery of University Clinical Center in Gdańsk, Poland e-mail: monika.lacka@gumed.edu.pl Available online: www.ejtcm.gumed.edu.pl Copyright ® Medical University of Gdańsk This is Open Access article distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International. TRANSPARENT PROCESS OPEN ACCESS Abstract
通讯作者:波兰格但斯克大学临床中心普通、内分泌和移植外科MonikaŁńcka电子邮件:monika.lacka@gumed.edu.pl在线获取:www.ejtcm.gumed.edu.pl版权所有®格但斯克医科大学这是一篇根据知识共享署名共享4.0国际条款发布的开放获取文章。透明进程开放访问摘要
{"title":"Duodenal diverticulum perforation mimicking acute cholecystitis- case reports and literature review","authors":"Monika Łącka, S. Hać","doi":"10.31373/ejtcm/139692","DOIUrl":"https://doi.org/10.31373/ejtcm/139692","url":null,"abstract":"Corresponding author: Monika Łącka, Department of General, Endoctrine and Transplant Surgery of University Clinical Center in Gdańsk, Poland e-mail: monika.lacka@gumed.edu.pl Available online: www.ejtcm.gumed.edu.pl Copyright ® Medical University of Gdańsk This is Open Access article distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International. TRANSPARENT PROCESS OPEN ACCESS Abstract","PeriodicalId":52409,"journal":{"name":"European Journal of Translational and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42623490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Translational and Clinical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1